Viking Therapeutics(us:VKTX)
23.91
-0.99%
Updated on 2025-04-02
Open:24.15
Close:23.91
High:24.54
Low:23.29
Prev Close:24.15
Volume:3.67M
Turnover:87.77M
Turnover Ratio:3.27%
Shares:112.25M
MarketCap:2.68B
About Viking Therapeutics
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Company Name: Viking Therapeutics
Address: 9920 Pacific Heights Boulevard,Suite 350
Employees: 27
Fiscar Year: 12-31
IPO Date: 2015-04-29
Website: http://www.vikingtherapeutics.com
CIK: 1607678
View all SEC Filings
About
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Address:9920 Pacific Heights Boulevard,Suite 350
Market Movers